Novartis says Japanese study shows Diovan reduces cardiovascular, stroke risk - Forbes.com

Novartis says Japanese study shows Diovan reduces cardiovascular, stroke risk - Forbes.com: "ZURICH (Thomson Financial) - Novartis AG said results from an independent study in Japan show use of its blood pressure drug Diovan, in combination with conventional therapy, can significantly reduce the risk of cardiovascular events and strokes."